(CG1) Amundi DAX DR - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: FR0010655712 • Germany Equity
CG1: German, Stocks, Equities, Index, Funds
The Amundi ETF DAX UCITS ETF DR (Ticker: CG1), listed on Euronext Paris (Exchange: PA), is a low-cost exchange-traded fund designed to provide investors with exposure to German equities. The fund tracks the Morningstar Germany Total Market Index (TME) NR EUR, which offers a market-capitalization-weighted representation of German companies, including large-cap, mid-cap, and small-cap firms. This ETF is part of Amundis UCITS ETF range, known for its transparency, liquidity, and regulatory compliance.
As of the latest data, the fund manages Assets Under Management (AUM) of approximately 1.06 billion EUR, indicating a substantial and liquid portfolio. This scale often translates into tighter bid-ask spreads, making it more cost-effective for traders and investors seeking exposure to the German market. The ETFs structure allows it to efficiently replicate the performance of its underlying index, aligning closely with the returns of German equities.
Looking ahead, the future outlook for the Amundi ETF DAX UCITS ETF DR will likely be shaped by broader macroeconomic trends, including Germanys role in the global economy, monetary policy decisions by the European Central Bank, and the performance of key sectors such as industrials, automotive, and technology. As markets evolve, the funds ability to maintain low tracking error and provide diversified exposure to German equities will remain critical to its appeal. While past performance is not indicative of future results, the funds structure and track record position it as a viable option for investors seeking targeted exposure to the German market.
Additional Sources for CG1 ETF
CG1 ETF Overview
Market Cap in USD | 1,156m |
Category | Germany Equity |
TER | 0.10% |
IPO / Inception | 2008-09-16 |
CG1 ETF Ratings
Growth 5y | 86.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | 18.2 |
Analysts | - |
Fair Price Momentum | 430.18 EUR |
Fair Price DCF | - |
CG1 Dividends
No Dividends PaidCG1 Growth Ratios
Growth Correlation 3m | 92.8% |
Growth Correlation 12m | 88.1% |
Growth Correlation 5y | 79.2% |
CAGR 5y | 19.84% |
CAGR/Max DD 5y | 0.74 |
Sharpe Ratio 12m | 1.74 |
Alpha | 17.98 |
Beta | 0.55 |
Volatility | 26.44% |
Current Volume | 5.9k |
Average Volume 20d | 4.2k |
As of March 14, 2025, the stock is trading at EUR 401.35 with a total of 5,911 shares traded.
Over the past week, the price has changed by -3.68%, over one month by -0.45%, over three months by +10.41% and over the past year by +24.80%.
Yes. Based on ValueRay Analyses, Amundi DAX DR (PA:CG1) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 86.50 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CG1 as of March 2025 is 430.18. This means that CG1 is currently overvalued and has a potential downside of 7.18%.
Amundi DAX DR has no consensus analysts rating.
According to ValueRays Forecast Model, CG1 Amundi DAX DR will be worth about 474.6 in March 2026. The stock is currently trading at 401.35. This means that the stock has a potential upside of +18.24%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 474.6 | 18.2% |